Target intelligence / Profile preview

Guanine nucleotide-binding protein Gs subunit alpha (Gs alpha (Gαs))

Target
Gs alpha (Gαs)
Molecular classification
G protein, Signal transduction protein, GTPase, Heterotrimeric G protein alpha subunit
01

Overview

Guanine nucleotide-binding protein Gs subunit alpha (Gs alpha, Gαs) is the stimulatory alpha subunit of the heterotrimeric G protein Gs. It acts as a molecular transducer for a wide range of cell surface receptors, especially G protein-coupled receptors (GPCRs), translating extracellular signals into intracellular responses. Upon activation by a receptor, Gs alpha exchanges GDP for GTP, dissociates from the beta-gamma complex, and activates adenylyl cyclase, dramatically raising intracellular cAMP levels. This second messenger then triggers several downstream pathways, notably Protein Kinase A (PKA) activation. Mutations in the Gs alpha gene (GNAS) are implicated in various diseases, including McCune-Albright syndrome and parathyroid hormone resistance[2][4][7]. Gs alpha is a well-established therapeutic target in endocrinology, neuroscience, and oncology.

Other names
Gs alpha subunitGαsGsαGTP-binding protein alpha subunit GsStimulatory G protein alpha subunit
02

Mechanism of action

Drugs may activate Gs-coupled GPCRs, leading to Gαs-mediated stimulation of adenylyl cyclase and increased cAMP. Some mutations cause constitutive activation, inducing cAMP production independently of GPCR stimulation.

03

Biological functions

Signal transductionRegulation of adenylyl cyclasecAMP generationRegulation of Protein Kinase A (PKA)Cellular responses to hormones and neurotransmitters
04

Disease associations

Endocrine disorders (e.g., pseudohypoparathyroidism)McCune-Albright syndromeTumor developmentParathyroid hormone resistance
05

Safety considerations

Oncogenic mutations (gain-of-function) can cause hormone-independent activation and tumor syndromesDysregulated cAMP signaling linked to metabolic and endocrine disordersPotential for non-specific activation or inhibition leading to broad physiological effects
06

Interacting drugs

Forskolin (activates adenylyl cyclase downstream of Gs alpha)

3 more in the full profile.

07

Biomarkers

Genetic mutations in the GNAS gene (for diagnosis of pseudohypoparathyroidism, McCune-Albright syndrome)cAMP levels (as a functional readout of Gs alpha activity)

Beyond the preview

Go deeper on Guanine nucleotide-binding protein Gs subunit alpha (Gs alpha (Gαs)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide-binding protein Gs subunit alpha (Gs alpha (Gαs)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call